Companies / Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc.
Nasdaq: WHWKCIK 1422142MORRISTOWN, NJ
Financials · FY2025
Ownership
57.0M shares outstanding · as of Aug 3, 2026
Ownership
| Insiders | 0.97% | 553,494 |
| Institutions | 62.77% | 35,782,143 |
| Public float | 36.26% | 20,673,373 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 5
View all →| Insider | % of shares | Shares |
|---|---|---|
Castelein CaleyDirector | 0.48% | 274,796 |
Ball BryanSee remarks | 0.36% | 206,019 |
Lennon David JamesCEOCHIEF EXECUTIVE OFFICER · Director | 0.08% | 44,579 |
Giacobello Scott M.CHIEF FINANCIAL OFFICER | 0.05% | 28,100 |
Maroun Richard EDirector | — | — |
Institutional holders 56
View all →| Holder | Value | % of shares |
|---|---|---|
| $15.92M | 8.10% | |
| $14.37M | 7.31% | |
| $8.95M | 6.49% | |
| $8.81M | 3.37% | |
| $8.25M | 5.98% | |
| $6.90M | 5.00% | |
| $5.24M | 3.80% | |
| $5.04M | 3.65% | |
| $5.01M | 3.63% | |
| $3.85M | 2.79% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common Stock | $7.44M | +1.6M +543.06% | 1,922,828 3.37% of shares | medium |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | New | Common Stock | $1.90M | +550K | 550,441 0.97% of shares | low |
| Q1 2026 as of | Ames National Corporation 13F manager | New | Common Stock | $1.33M | +5K | 4,571 <0.01% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common Stock | $1.11M | +241K +165.90% | 386,982 0.68% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | New | Common Stock | $1.07M | +310K | 309,674 0.54% of shares | low |
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common Stock | $198.7K | +58K | 57,597 0.10% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Exit | Common Stock | $-164.5K | -68K -100.00% | 0 | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common Stock | $145.0K | +32K | 31,668 0.06% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| WHWK | Common Stock | 00032Q104 |